Cambodia vs Kazakhstan: Treatment success rate for patients treated for MDR-TB
Cambodia
85.0%
in 2022
Kazakhstan
84.0%
in 2022
Cambodia rank
35th
Kazakhstan rank
38th
Treatment success rate for patients treated for MDR-TB over time
- Cambodia
- Kazakhstan
How they compare
Cambodia currently reports 85.0% against 84.0% in Kazakhstan, a difference of 1.0%.
The two have swapped places 5 times across 16 shared years of data; in 2007 it was Kazakhstan ahead.
Cambodia ranks 35th and Kazakhstan ranks 38th of 163 countries.
Across the 3 decades both report, Cambodia averaged higher in 1 and Kazakhstan in 2.
Head to head by decade
| Decade | Cambodia | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.7% | 74.7% | 3.0% | Kazakhstan |
| 2010s | 75.4% | 76.4% | 1.0% | Kazakhstan |
| 2020s | 84.3% | 80.7% | 3.7% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Cambodia or Kazakhstan?
- Cambodia, at 85.0% against 84.0% in Kazakhstan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Cambodia and Kazakhstan?
- 1.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Kazakhstan?
- 16 years are reported by both, from 2007 to 2022.
- How do Cambodia and Kazakhstan rank globally for treatment success rate for patients treated for mdr-tb?
- Cambodia ranks 35th and Kazakhstan ranks 38th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.